New Appropriate Use Criteria for Coronary Revascularisation
The American College of Cardiology and several partner organisations have released updated appropriate use criteria for performing coronary revascularisation in patients with acute coronary syndromes (ACS). The document includes clinical scenarios that are scored to indicate whether revascularisation is appropriate, may be appropriate or is rarely appropriate for the clinical scenario presented. The new criteria are published online in Journal of the American College of Cardiology.
See Also: Towards Optimal Management of Left Main Coronary Artery Disease
The criteria serve as an overall guide and physicians should evaluate each case on an individual basis, according to the writing committee, which is headed by Manesh R. Patel, MD, FACC, FAHA, FSCAI, chief of the division of cardiology and co-director of the Duke Heart Center at Duke University.
"This update provides a reassessment of clinical scenarios that the writing group felt to be affected by significant changes in the medical literature or gaps from prior criteria," explains Dr. Patel. The clinical scenarios have been developed to mimic patient presentations that may be encountered in everyday practice and information on symptom status, presence of clinical instability or ongoing ischaemic symptoms, prior reperfusion therapy, risk level as assessed by noninvasive testing, fractional flow reserve testing, and coronary anatomy.
Patients with ACS suffer from sudden, reduced blood flow to the heart, requiring quick diagnosis and care. Coronary revascularisation is the restoration of this blood flow to the heart commonly by coronary artery bypass graft or percutaneous coronary intervention.
"The primary objective of the appropriate use criteria is to provide a framework for the assessment of practice patterns that will hopefully improve physician decision making and ultimately lead to better patient outcomes," adds Dr. Patel. Also, the document can help to better inform patients about their treatment options. It is important for patients to discuss revascularisation and engage in shared decision making with their provider to come to a decision on the best treatment plan.
The document is part one of a two-part revision for coronary revascularisation. The updated appropriate use criteria for coronary revascularisation in patients with stable ischemic heart disease are forthcoming.
Source: American College of Cardiology
Image Credit: Wikimedia Commons
Published on : Sat, 24 Dec 2016
The Connex® Spot Monitor features an easy-to-use, vivid touchscreen display and provides accurate vital signs measurement including blood pressure averaging, spot checking, interval monitoring and custom scoring across patient populations. The device...
Unbelievably small and light mechanical chest compression device In case of a sudden cardiac arrest, immediate chest compressions are required. Performing manual chest compressions well for an extended period of time is almost impossible. Thanks to...
The CNAP® Monitor 500 HD standalone is designed for continuous noninvasive hemodynamic monitoring in a wide range of applications, i.e. electrophysiology, operating theatres, critical- and intermediate care, emergency room and transport.
Emergency monitor and defibrillator with touchscreen The DEFIGARD Touch 7 is an indispensable tool for rescuers. The device is extremely compact and offers the latest defibrillation technology in combination with comprehensive monitoring functions....
By lifting up the device cover, the FRED PA-1 starts up immediately and guides the rescuer step-by-step during the entire resuscitation process. The FRED PA-1 is available either as semi-automatic or fully automatic device.In its automatic version,...